News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Rami Manochakian: The FDA approves 1st line Osimertinib WITH chemotherapy for advanced EGFRm NSCLC.
Photo taken from google images
Feb 17, 2024, 15:57

Rami Manochakian: The FDA approves 1st line Osimertinib WITH chemotherapy for advanced EGFRm NSCLC.

Rami Manochakian, Thoracic Oncologist and Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter:

“Hot off the press.

The FDA approves 1st line Osimertinib WITH chemotherapy for advanced EGFRm non-small cell Lung Cancer.
Approval based on FLAURA2 trial which showed PFS compared to Osimertinib alone.

HR: 0.62
mPFS: 25.5 vs 16.7 months.”

Rami Manochakian: The FDA approves 1st line Osimertinib WITH chemotherapy for advanced EGFRm NSCLC.

View additional information.
Source: Rami Manochakian/X

advanced EGFRm NSCLC cancer FLAURA2 Lung cancer non small cell lung cancer OncoDaily Oncology osimertinib Rami Manochakian
Special Coverage
Blog
Jan 16, 2025, 10:18
Elizabeth Ugwoma Awo-Ejeh: Lessons I Learned from My Breast Cancer Journey
Science
Jan 16, 2025, 10:17
Jason Sheehan: Preoperative versus postoperative SRS for brain metastasis
Blog
Jan 16, 2025, 10:13
Elizabeth McKenna: The January issue of Cancer Discovery is now online
Oncologist Near Me
Jan 16, 2025, 10:07
Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology
Blog
Jan 16, 2025, 10:01
Narjust Florez and Alfredo Addeo dive into the data from ESMO - IASLC
Insight
Jan 16, 2025, 09:56
N-Power Medicine Acquired Syapse to Enhance Oncology Research Network
Dialogues
Jan 16, 2025, 09:53
ColoSense: Advancing Noninvasive Colorectal Cancer Screening Through Innovative Diagnostics
Science
Jan 16, 2025, 09:48
Sarbajit Mukherjee: Excited to share my 50th publication from Roswell Park
Insight
Jan 16, 2025, 09:37
Laura Bukavina: Age doesn't limit EV efficacy
Blog
Jan 16, 2025, 09:28
Glenn J. Hanna: Multidisciplinary approach to treat HPV-driven oropharyngeal cancer
Societies
Jan 16, 2025, 09:23
A look back on 2024 MCI Precision Oncology - Miami Cancer Institute Research
Societies
Jan 16, 2025, 09:17
MD Anderson has received a $10 million gift to support Be Well Beaumont initiative